Clinical Trial Update: Pediatric High-Risk Deep Venous Thrombosis Lytic Outcomes Trial [Phase 3]

View source ↗

Summary

Phase 3 pediatric trial for high-risk deep venous thrombosis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Post-thrombotic Syndrome

Snippet

Sponsor: University of Colorado, Denver | Conditions: Deep Vein Thrombosis, Post-Thrombotic Syndrome | Phase 3 | Status: WITHDRAWN